胺碘酮联合琥珀酸美托洛尔对慢性心力衰竭合并快室率心房颤动的临床意义研究

Clinical significance research of Amiodarone combined with Metoprolol Succinate for chronic heart failure complicated with rapid ventricular rate atrial fibrillation

目的研究胺碘酮联合琥珀酸美托洛尔对慢性心力衰竭合并快室率心房颤动的临床意义。方法 80例慢性心力衰竭合并快室率心房颤动患者,随机分为试验组和对照组,各40例。对照组采取胺碘酮治疗,试验组在对照组基础上使用琥珀酸美托洛尔治疗。比较两组患者的临床疗效。结果治疗后,试验组总有效率为100.0%,高于对照组的87.5%,差异有统计学意义(P<0.05)。结论对慢性心力衰竭合并快室率心房颤动患者使用胺碘酮联合琥珀酸美托洛尔治疗,可以明显提高患者的临床疗效,提高患者的生活质量,值得临床推广。

Objective To research the clinical significance of Amiodarone combined with Metoprolol Succinate for chronic heart failure complicated with rapid ventricular rate atrial fibrillation.Methods A total of 80 cases of chronic heart failure complicated with rapid ventricular rate atrial fibrillation were randomly divided into experimental group and control group,40 cases in each group.The control group was treated with Amiodarone,the experimental group was treated with Metoprolol Succinate on the basis of the control group.The clinical efficacy of the two groups was compared.Results After treatment,the total effective rate of the experimental group was 100.0%,which was significantly higher than 87.5%of the control group,the difference was statistically significant(P<0.05).Conclusion The application of Amiodarone combined with Metoprolol Succinate for chronic heart failure complicated with rapid ventricular rate atrial fibrillation can significantly improve the clinical efficacy and the quality of life of patients,it is worthy of clinical promotion.